LEMAITRE VASCULAR INC (LMAT) Share-based Payment Arrangement, Expense USD 2015 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Lemaitre Vascular Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2015 to 2024.
  • Lemaitre Vascular Inc Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $1.61 M, a 24.8% increase year-over-year.
  • Lemaitre Vascular Inc Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $5.64 M, a 31.3% increase year-over-year.
  • Lemaitre Vascular Inc annual Share-based Payment Arrangement, Expense for 2023 was $5.32 M, a 27.5% increase from 2022.
  • Lemaitre Vascular Inc annual Share-based Payment Arrangement, Expense for 2022 was $4.17 M, a 19.9% increase from 2021.
  • Lemaitre Vascular Inc annual Share-based Payment Arrangement, Expense for 2021 was $3.48 M, a 15.1% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $5.64 M $1.61 M +$320 K +24.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $5.32 M $1.4 M +$720 K +105% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $4.6 M $1.31 M +$127 K +10.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $4.47 M $1.31 M +$176 K +15.5% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $4.3 M $1.29 M +$123 K +10.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $4.17 M $684 K -$202 K -22.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $4.38 M $1.19 M +$389 K +48.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $3.99 M $1.14 M +$267 K +30.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $3.72 M $1.17 M +$240 K +25.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $3.48 M $886 K +$133 K +17.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $3.35 M $797 K +$110 K +16% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $3.24 M $869 K +$66 K +8.22% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $3.17 M $927 K +$148 K +19% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $3.02 M $753 K +$206 K +37.7% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $2.82 M $687 K +$32 K +4.89% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $2.78 M $803 K +$109 K +15.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $2.68 M $779 K +$33 K +4.42% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $2.64 M $547 K -$8 K -1.44% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $2.65 M $655 K +$118 K +22% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $2.53 M $694 K +$58 K +9.12% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $2.47 M $746 K +$125 K +20.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $2.35 M $555 K +$145 K +35.4% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-12
Q3 2018 $2.2 M $537 K -$350 K -39.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $2.55 M $636 K +$164 K +34.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $2.39 M $621 K +$134 K +27.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-06
Q4 2017 $2.26 M $410 K -$75 K -15.5% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-12
Q3 2017 $2.33 M $887 K +$354 K +66.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-02
Q2 2017 $1.98 M $472 K +$140 K +42.2% Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-03
Q1 2017 $1.84 M $487 K +$157 K +47.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 $1.68 M $485 K +$149 K +44.3% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-11
Q3 2016 $1.53 M $533 K +$54 K +11.3% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 $1.48 M $332 K +$51 K +18.1% Apr 5, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $1.43 M $330 K +$2 K +0.61% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $1.42 M $336 K Oct 1, 2015 Dec 31, 2015 10-K 2018-03-09
Q3 2015 $479 K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 $281 K Apr 4, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $328 K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.